EphB4 gene polymorphism and protein expression in non-small-cell lung cancer

Zheng,Ming-Feng; Ji,Yong; Wu,Xiao-Bo; Ye,Shu-Gao; Chen,Jing-Yu

doi:10.3892/mmr.2012.936

August 2012 Volume 6 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August 2012 Volume 6 Issue 2

Full Size Image

Article

EphB4 gene polymorphism and protein expression in non-small-cell lung cancer

Authors:
- Ming-Feng Zheng
- Yong Ji
- Xiao-Bo Wu
- Shu-Gao Ye
- Jing-Yu Chen
View Affiliations / Copyright

Affiliations: Department of Cardiothoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214023, P.R. China
Pages: 405-408
|
Published online on: June 6, 2012

https://doi.org/10.3892/mmr.2012.936
Expand metrics +

Abstract

The objective of this study was to identify new diagnostic, prognostic or therapeutic molecules for non-small- cell lung cancer (NSCLC). We investigated the expression of EphB4, a tyrosine kinase receptor which has been shown to act as a tumor promoter in other cancers. Using immunohistochemistry, we visualized EphB4 expression in 28 samples of NSCLC and 12 samples of adjacent normal tissues. Additionally, we assessed a single-nucleotide polymorphism in EphB4 to determine its effect on protein expression. The correlation of both genotype and protein expression with disease severity was determined. EphB4 was expressed in 53.6% of patients with lung cancer, a significant increase compared to control lung samples (0.0%, P<0.05). Furthermore, EphB4 expression was correlated with differentiation, lymph node metastasis and TNM stage of tumors (P<0.05). Additionally, the polymorphism in EphB4 at rs314310 appeared to correspond to protein expression and disease susceptibility. While the frequencies of CC, CA and AA genotypes were not different between lung cancer patients and healthy controls, the frequencies of C and A alleles were significantly different between these groups (P<0.05). Further analysis showed that the positive rate of EphB4 expression in patients with the AA genotype was significantly higher compared to that in patients with other genotypes (P<0.05). Overexpression of EphB4 plays a role in the occurrence and development of NSCLC, and the polymorphism at rs314310 may predispose individuals to this disease.

View Figures

View References

1	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar
2	Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66. 2007. View Article : Google Scholar
3	Yang L, Parkin DM, Li LD, Chen YD and Bray F: Estimation and projection of the national profile of cancer mortality in China: 1991–2005. Br J Cancer. 90:2157–2166. 2004.PubMed/NCBI
4	Murray T, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar
5	Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar
6	Pasquale EB: Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol. 6:462–475. 2005. View Article : Google Scholar : PubMed/NCBI
7	Erber R, Eichelsbacher U, Powajbo V, et al: EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J. 25:628–641. 2006. View Article : Google Scholar : PubMed/NCBI
8	Kumar SR, Singh J, Xia G, et al: Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol. 169:279–293. 2006. View Article : Google Scholar : PubMed/NCBI
9	Shimosato Y: Histological typing of lung and pleural tumors (3rd edition, 1999): malignant epithelial tumors. Nihon Rinsho. 60:123–131. 2002.PubMed/NCBI
10	Shen LQ, Wang XC, Zhao J, Di HZ and Zhuang ZX: Association between Eph4 gene polymorphism and non-small cell lung cancer. Chin J Clin Oncol. 31:778–779. 2009.PubMed/NCBI
11	Lahiri DK and Schnabel B: DNA isolation by a rapid method from human blood samples: effects of MgCl₂, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet. 31:321–328. 1993. View Article : Google Scholar : PubMed/NCBI
12	Yarden Y and Ullrich A: Growth factor receptor tyrosine kinases. Annu Rev Biochem. 57:443–478. 1988. View Article : Google Scholar : PubMed/NCBI
13	Himanen JP and Nikolov DB: Eph signaling: a structural view. Trends Neurosci. 26:46–51. 2003. View Article : Google Scholar : PubMed/NCBI
14	Wang HU, Chen ZF and Anderson DJ: Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 93:741–753. 1998. View Article : Google Scholar : PubMed/NCBI
15	Cheng N, Brantley DM and Chen J: The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev. 13:75–85. 2002. View Article : Google Scholar : PubMed/NCBI
16	Stephenson SA, Slomka S, Douglas EL, Hewett PJ and Hardingham JE: Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer. BMC Mol Biol. 2:15–17. 2001. View Article : Google Scholar : PubMed/NCBI
17	Takai N, Miyazaki T, Fujisawa K, Nasu K and Miyakawa I: Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer. Oncol Rep. 8:567–573. 2001.PubMed/NCBI
18	Nowotny P, Kwon JM and Goate AM: SNP analysis to dissect human traits. Curr Opin Neurobiol. 11:637–641. 2001. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

EphB4 gene polymorphism and protein expression in non-small-cell lung cancer

This article is mentioned in:

Abstract

Related Articles